期刊文献+

2型糖尿病患者C-反应蛋白与胰岛素抵抗关系研究 被引量:2

下载PDF
导出
摘要 目的:T2DM患者血浆C反应蛋白(CRP)水平变化并探讨与胰岛素抵抗的关系。方法:受试者分为二组:T2DM组80例和正常对照组40例。所有研究对象于禁食12h后次晨空腹静脉取血,测定空腹血糖(FPG)、空腹血浆胰岛素(FINS),空腹C-反应蛋白(CRP),并计算HOMA-IR指数(FPG×FINS)/22.5,并对导致血清CRP改变的因素进行相关分析。结果:(1)CRP水平的比较DM组CRP水平明显高于对照组(均P<0.05);(2)HO-MA—IR指数的比较T2DM组IR均显著高于对照组(均P<0.05)。结论:FPG、FINS的变化DM组均高于对照组(均P<0.05);CRP与IR、FPG、FINS呈正相关,表明CRP与IR、DM的发生、发展及预后有着密切的关联,提示CRP的增高参与了IR和胰岛功能的损害,可作为T2DM患者预测预后的指标之一。
出处 《赣南医学院学报》 2008年第6期873-874,共2页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
  • 相关文献

参考文献3

  • 1Barzilay JI, Abraham L, Heckbert SR, et al. The relation ofmarkers of inflammation to the development of glucose disorders inthe elderly: the cardiovascular heath study [ J ]. Diahites ,2002,50 (10) :2384 - 2389.
  • 2龙敏.C-反应蛋白和糖尿病[J].国外医学(内分泌学分册),2002,22(2):75-77. 被引量:78
  • 3Anan Takahashi N, Nakagawa M. High - sensitivity C - reactiveprotein is associated with insulin resistance and cardiovascularautonomi c dysfunction in type 2 diabetic patients [ J ]. Metabolism,2005,54 (4) :552 - 558.

二级参考文献20

  • 1Duclos T W. Function of c-reactive protein [J]. Ann Med, 2000,32:274-278.
  • 2Volanakis J E. Human c-reactive protein: expression,structure, and function [J]. Mol Immunol,2001,38:189-197.
  • 3Ford E S. Body mass index, diabetes, and c-reactive protein among U S adults [J]. Diabetes Care,1999,22:1971-1977.
  • 4Barzilay J I, Abraham L, Heckbert S R, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study[J]. Diabetes,2001,50:2384-2389.
  • 5Pickup J C, Crook M A. Is type 2 diabetes mellitus a disease of the innate immune system? [J].Diabetologia, 1998,41:1241-1248.
  • 6Pickup J C, Mattock M B, Chusney G D, et al.NIDDM as a disease of the innate immune system:association of acute phase reactants and interleukin-6 with metabolic syndrome X [ J]. Diabetologia, 1997,40:1286-1292.
  • 7Pradhan A D, Manson J E, Rifai N, et al. C-reactive protein,interleukin 6,and risk of developing type2 diabetes mellitus [J]. JAMA,2001,286:327-333.
  • 8Festa A, Agostno R D, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome [J]. Circulation, 2000,102:42-47.
  • 9Oaes O N, Akca H, Nayo L D, et al. A phosphatidylinositol 3 - Kinase / Akt / mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-l[J]. Proc Natl Acad Sci USA,2001,10:4640-4645.
  • 10John A, Colwell M D. Inflammation and diabetic vascular complications [J]. Diabetes Care, 1999,22:1927-1928.

共引文献77

同被引文献8

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部